SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-30
👔
HALOZYME THERAPEUTICS, INC.
@HALO_InsiderForm 4 Filing: Krishnan Mahesh Sells $828,711.84 of $HALO
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
HALOZYME THERAPEUTICS, INC.
Ticker: $HALO
Transaction Value
$828,711.84
Price/Share: $56.73
transaction date
2026-06-29
Shares: 14,608
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Krishnan Mahesh, holds the title of Director at HALOZYME THERAPEUTICS, INC..
On 2026-06-29, the insider transacted 14,608 shares.The shares were transacted at a weighted average price of $56.73 per share, resulting in a total market-relevant value of $828,711.84.
Executive Summary Summary
Krishnan Mahesh (Director) sold $829K of $HALO
Post-Transaction Position: 14,462 shares
SEC Accession No: 0001159036-26-000082 (CIK: 1866746)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.